학술논문

LBA54 Ipilimumab or FOLFOX in combination with nivolumab and trastuzumab in previously untreated HER2 positive locally advanced or metastastic esophagogastric adenocarcinoma (EGA): Results of the randomized phase II INTEGA trial (AIO STO 0217)
Document Type
Abstract
Source
In Annals of Oncology September 2021 32 Supplement 5:S1331-S1331
Subject
Language
ISSN
0923-7534